Ligand validation:6JZ2

SJ5: (3S,4R,5R)-4,5-dihydroxypiperidine-3-carboxylic acid

SJ5 is a Ligand Of Interest in 6JZ2 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6JZ2_SJ5_A_701	97%	41%	0.069	0.981	0.52	1.74	-	1	0	0	100%	1
6JZ2_SJ5_B_701	95%	41%	0.072	0.978	0.58	1.68	-	1	0	0	100%	1
5Z19_SJ5_A_701	77%	11%	0.125	0.966	0.61	3.45	-	3	0	0	100%	1
8OHU_SJ5_AAA_501	99%	48%	0.049	0.986	0.85	1.16	-	2	0	0	100%	1
5Z1A_SJ5_A_701	94%	14%	0.077	0.975	1.39	2.48	2	2	0	0	100%	1
6LDB_SJ5_D_701	83%	34%	0.098	0.957	0.94	1.63	-	4	1	0	100%	1
8BAC_SJ5_AAA_604	74%	55%	0.098	0.926	0.72	1.01	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.